Certain embodiments generally relate to photoacoustic imaging, and more specifically, to methods and systems the employ photoacoustic computed tomography.
Breast cancer is the second most common cancer to affect women in the United States and is the second ranked cause of cancer-related deaths. About 1 in 8 women in the United States will develop invasive breast cancer during their lifetime as discussed in Siegel, R. L., Miller, K. D. & Jemal, A., Cancer statistics, 2017, CA Cancer J. Clin. 67, pp. 7-30 (2017), which is hereby incorporated by reference for this discussion. Multiple large prospective clinical trials have demonstrated the importance of early detection in improving breast cancer survival as discussed, for example, in Dizon, D. S. et al., “Clinical cancer advances 2016: annual report on progress against cancer from the American Society of Clinical Oncology,” J. Clin. Oncol. 34, pp. 987-1011 (2016), Miller, A. B. et al., “Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial,” BMJ 348, 366 (2014), and Burton, R. & Bell, R., “The global challenge of reducing breast cancer mortality,” Oncologist 18, pp. 1200-1201 (2013), which are hereby incorporated by reference in their entireties. While mammography is currently the gold standard used for breast cancer screening, it utilizes ionizing radiation and has lower sensitivity in women with dense breasts as discussed in Pinsky, R. W. & Helvie, M. A., “Mammographic breast density: effect on imaging and breast cancer risk,” J. Natl. Compr. Canc. Netw. 8, pp. 1157-1165 (2010) and Freer, P. E., Mammographic breast density: impact on breast cancer risk and implications for screening, Breast Imaging 35, e352140106 (2014), which are hereby incorporated by reference in their entireties for this discussion. Ultrasonography has been used as an adjunct to mammography, but can suffer from speckle artifacts and low specificity as discussed in Devolli-Disha, E., Manxhuka-Kerliu, S., Ymeri, H. & Kutllovci, A., “Comparative accuracy of mammography and ultrasound in women with breast symptoms according to age and breast density,” Bosn. J. Basic. Med. Sci. 9, pp. 131-136 (2009) and Hooley, R. J., Scoutt, L. M. & Philpotts, L. E., “Breast ultrasonography: state of the art,” Radiology 268, p. e13121606 (2013), which are hereby incorporated by reference in their entireties for this discussion. Magnetic resonance imaging (MRI) poses a large financial burden and requires the use of intravenous contrast agents that can cause allergy, kidney damage, and permanent deposition in the central nervous system, as discussed respectively in Murphy, K. J., Brunberg, J. A. & Cohan, R. H., “Adverse reactions to gadolinium contrast media: a review of 36 cases,”Am. J. Roentgenol. 167, pp. 847-849 (1996), Perazella, M. A., “Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis,” Curr. Drug Saf 3, pp. 67-75 (2008), and Ibrahim, D., Froberg, B., Wolf, A. & Rusyniak, D. E., “Heavy metal poisoning: clinical presentations and pathophysiology, Clin. Lab. Med. 26, pp. 67-97 (2006), which are hereby incorporated by reference in their entireties for this discussion. Diffuse optical tomography has been investigated to provide functional optical contrast. However, the spatial resolution of current prototypes may limit their clinical use as discussed in Choe, R. et al., “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32,1128-1139 (2005) and Culver, J. P. et al., “Three-dimensional diffuse optical tomography in the parallel plane transmission geometry: evaluation of a hybrid frequency domain/continuous wave clinical system for breast imaging,”Med. Phys. 30, pp. 235-247 (2003), which are hereby incorporated by reference in their entireties for this discussion.
Certain aspects pertain to photoacoustic computed tomography (PACT) methods and/or systems that can be used, for example, to image breast tissue and other biological tissues.
Certain aspects pertain to photoacoustic computed tomography (PACT) systems. In one implementation, a PACT system comprises at least one pulsed or modulated light source, an ultrasonic transducer array comprising unfocused transducer elements, and a scanning mechanism configured to move and/or scan the ultrasonic transducer array along the axis. Each unfocused transducer element having a field-of-view in a range of 5 degrees to 30 degrees in a direction along an axis. In one example, the ultrasonic transducer array is a full-ring ultrasonic transducer array and the unfocused transducer elements are distributed around a circumference of a ring centered about the axis.
Certain aspects pertain to a photoacoustic computed tomography (PACT) methods. In one implementation, a PACT method comprises causing at least one pulsed light source to generate one or more light pulses configured to illuminate a specimen being imaged. The method further comprises controlling a scanning mechanism to move and/or scan the ultrasonic transducer array in a direction along an axis, wherein the ultrasonic transducer array includes a plurality of unfocused transducer elements, wherein the ultrasonic transducer array is moved/scanned in the direct along the axis while each of a plurality of unfocused transducer elements detects photoacoustic waves within a field-of-view in a range of 5 degrees to 30 degrees in the direction along the axis. In addition, the method comprises reconstructing a plurality of 2D images and/or a 3D volumetric image using photoacoustic signals recorded while the scanning mechanism moves/scans the ultrasonic transducer array in the direction along the axis.
Certain aspects pertain to a method of imaging breast issue of a subject. The method comprises providing breast tissue being imaged, scanning the breast tissue within the imaging field using photoacoustic computed tomography, and reconstructing a 3D volumetric image using 3D back projection and/or a plurality of 2D images using 2D back projection.
These and other features are described in more detail below with reference to the associated drawings.
These and other features are described in more detail below with reference to the associated drawings.
Different aspects are described below with reference to the accompanying drawings. The features illustrated in the drawings may not be to scale. Different aspects are described below with reference to the accompanying drawings. The features illustrated in the drawings may not be to scale. In the following description, numerous specific details are set forth in order to provide a thorough understanding of the presented embodiments. The disclosed embodiments may be practiced without one or more of these specific details. In other instances, well-known operations have not been described in detail to avoid unnecessarily obscuring the disclosed embodiments. While the disclosed embodiments will be described in conjunction with the specific embodiments, it will be understood that it is not intended to limit the disclosed embodiments.
Certain aspects pertain to photoacoustic computed tomography (PACT) methods. In one aspect, a PACT method performs elastographic evaluation of a plurality of 2D photoacoustic images acquired at a high frame rate (e.g., at least 10 Hz) at a cross-sectional depth. In some cases, the elastographic evaluation is performed for each of a plurality of depths. The 2D photoacoustic images may be acquired by a PACT system or other imaging system that can acquires 2D images at a high frame rate. The high imaging speed allows for differentiation in compliance (or stiffness) between tumors and surrounding normal tissue. Tumors tend to be less compliant, deforming to a lesser extent, than surrounding normal tissue. This PACT method can differentiate between tumors and surrounding normal tissue by analyzing the differential compliance in the 2D images taken at high speed of a cross-section. This differential compliance may be used as another contrast for detecting masses of interest in biological tissues.
Certain aspects pertain to photoacoustic computed tomography (PACT) systems. In one aspect, a PACT system is configured to reconstruct a 3D volumetric image, e.g., to image detailed angiographic structures in human breasts and other biological tissues. For example, certain PACT systems can image with deep penetration depth (e.g., 4 cm in vivo) at high spatial resolution (e.g., 255-μm in-plane resolution) and/or high temporal resolutions (e.g., 10-Hz frame rate). These PACT systems and methods can be used to scan an ultrasonic transducer array through the depth of a breast within a single breath hold, which is typically less than about 15 seconds or less than about 10 seconds. A 3D back projection technique can be used to reconstruct a 3D volumetric with negligible breathing-induced motion artifacts from the photoacoustic data. Other examples of specimens that can be imaged using these PACT systems and methods would be contemplated.
In certain implementations, PACT techniques may be used to clearly image and reveal tumors by observing higher blood vessel densities associated with tumors at high spatial resolution. This imaging capability shows early promise for high sensitivity in radiographically-dense breasts. In addition to blood vessel imaging, high imaging speed-enabled dynamic implementations of certain PACT techniques, such as those that utilize photoacoustic elastography, may be able to identify tumors by showing less compliance in the tumors in comparison to surrounding tissue. Certain implementations of PACT techniques are capable of imaging breasts with sizes ranging from B cup to DD cup, and skin pigmentations ranging from light to dark. Certain PACT techniques can be used to identify tumors without any ionizing radiation or exogenous contrast, and thus, avoid the associated health risks.
In certain implementations, PACT techniques employ a single-breath-hold 3D imaging mode where the ultrasonic transducer array with unfocused elements is scanned through a depth of the breast (or other biological tissue) during the duration of a typical breath hold (about 15 sec). The unfocused transducer elements detect photoacoustic waves within their angle of view. The data acquired during this mode of operation can reveal detailed angiographic structures in human breasts. Certain SBH-PACT techniques feature penetration depth (e.g., up to 4 cm in vivo) with high spatial and/or temporal resolutions (e.g., with 255-μm in-plane resolution and/or a 10-Hz two-dimensional (2D) frame rate). By scanning the breast within a single breath hold, a volumetric image can be acquired and subsequently reconstructed utilizing 3D back projection with negligible breathing induced motion artifacts. By employing a single-breath-hold data acquisition mode, these PACT systems and methods may clearly reveal tumors by observing higher blood vessel densities associated with tumors at high spatial resolution, showing early promise for high sensitivity in radiographically dense breasts. Other examples of specimens that can be held or kept from moving during the time period of about 15 seconds and imaged with this technique would be contemplated.
In addition to blood vessel imaging, certain implementations of PACT techniques employ a dynamic 2D imaging mode where the ultrasonic transducer array with unfocused elements is moved to one or more depths (elevational locations) of the breast or other biological tissue. At each depth, the unfocused transducer elements detect photoacoustic signals from their angle of view. By employing a dynamic mode, these techniques may be used to identify tumors by showing less compliance in the tumors as compared to the surrounding tissue.
Photoacoustic computed tomography (PACT) techniques ultrasonically image optical contrast via the photoacoustic effect. PACT techniques may be able to break through the about 1 mm optical diffusion limit on penetration for high-resolution optical imaging in deep tissues. Some examples of photoacoustic tomography are described in Xia, J., Yao, J. & Wang, L. V., “Photoacoustic tomography: principles and advances,” Electromagn. Waves 147, pp. 1-22 (2015) and Razansky, D. et al., “Multispectral opto-acoustic tomography of deep-seated fluorescent proteins in vivo,” Nat. Photon. 3, 412-417 (2009), which are hereby incorporated by reference in their entireties. PACT techniques combine the functional optical contrast of diffuse optical tomography and the high spatial resolution of ultrasonography. The rich contrast from optical absorption, which is related to various intrinsic and extrinsic contrast origins, enables PACT techniques to be able to perform structural, functional, and molecular imaging. A discussion of employing photoacoustic tomography for functional and molecular imaging can be found in Yao, J., Xia, J. & Wang, L. V., “Multi-scale functional and molecular photoacoustic tomography,” Ultrason. Imag. 38, pp. 44-62 (2016), which is hereby incorporated by reference in its entirety.
When a short-pulsed laser irradiates biological tissues, some of the delivered energy is absorbed and converted into heat, leading to transient thermoelastic expansion generating ultrasonic waves or emissions (sometimes referred to herein as “photoacoustic waves” or “PA waves”). The ultrasonic waves can be measured by an ultrasonic transducer to reconstruct the optical absorption distribution in the tissue to generate photoacoustic images as discussed in Zhou, Y., Yao, J. & Wang, L. V., “Tutorial on photoacoustic tomography,” J. Biomed. Opt. 21, 061007 (2016), which is hereby incorporated by reference in its entirety. For example, the 1/e attenuation coefficient for light in an him average breast is in a range of 1.0 to 1.3 cm −1 as discussed in Durduran, T., “Bulk optical properties of healthy female breast tissue,” Phys. Med. Biol. 47, pp. 2847-2861 (2002), which is hereby incorporated by reference in its entirety. Whereas the 1/e attenuation coefficient for mammographic X-rays is in a range of 0.5-0.8 cm−1as discussed in Heine, J. J. & Thomas, J. A, “Effective X-ray attenuation coefficient measurements from two full field digital mammography systems for data calibration applications,” Biomed. Eng. Online 7, 13 (2008), which is hereby incorporated by reference in its entirety. That is, the optical absorption contrast of soft tissue is much higher than X-ray contrast as discussed in Fang, Q. et al., “Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imag. 28, pp. 30-42 (2009), which is hereby incorporated by reference in its entirety. In some cases, PACT techniques may provide high spatial and temporal resolutions in imaging breast tissue with sufficiently deep nonionizing optical penetration. Some examples of photoacoustic imaging are discussed in Mallidi, S., Luke, G. P. & Emelianov, S., “Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance,” Trends Biotechnol. 29, 213-221 (2011) and Wang, L. V., “Multiscale photoacoustic microscopy and computed tomography,” Nat. Photon. 3, 503-509 (2009), which are hereby incorporated by reference in their entireties. As the principal optical absorber in the near infrared region, hemoglobin provides an endogenous contrast for imaging of blood vessels.
Generally speaking, a high density of blood vessels tends to correlate with angiogenesis. A discussion of angiogenesis can be found in Weidner, N., Semple, J. P., Welch, W. R. & Folkman, J., “Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma,” N. Engl. J. Med. 324, 1-8 (1991), Schneider, B. P. & Miller, K. D., “Angiogenesis of breast cancer,” J. Clin. Oncol. 23, 1782-1790 (2005), and Reynolds, A. R. et al., “Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors,” Nat. Med. 15, 392-400 (2009), which are hereby incorporated by reference in their entireties. Angiogenesis may play an important role in tumor growth and metastasis as discussed in Folkman, J., “Role of angiogenesis in tumor growth and metastasis,” Semin. Oncol. 29, 15-18 (2002), which is hereby incorporated by reference in its entirety.
Some photoacoustic imaging systems that have been used to image human breasts are mentioned in Toi, M. et al., “Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector array,” Sci. Rep. 7, 41970 (2017) (hereinafter referred to as “Toi”), Kruger, R. A. et al., “Dedicated 3D photoacoustic breast imaging,”Med. Phys. 40, 113301 (2013) (hereinafter referred to as “Kruger”) Wang, D. et al., “Deep tissue photoacoustic computed tomography with fast and compact laser system,” Biomed. Opt. Express 8, 112-123 (2017), Heijblom, M., Steenbergen, W. & Manohar, S., “Clinical photoacoustic breast imaging: the Twente experience,” IEEE Pulse 6, 42-46 (2015), Heijblom, M. et al., “Photoacoustic image patterns of breast carcinoma and comparisons with magnetic resonance imaging and vascular stained histopathology,” Sci. Rep. 5, 11778 (2015), Fakhrejahani, E. et al., “Clinical report on the first prototype of a photoacoustic tomography system with dual illumination for breast cancer imaging,” PloS ONE 10, e0142287 (2015), Kitai, T. et al., “Photoacoustic mammography: initial clinical results,” Breast Cancer 21, 146-153 (2014), Ermilov, S. A. et al., “Laser optoacoustic imaging system for detection of breast cancer,” J. Biomed. Opt. 14, 024007 (2009), Ke, H., Erpelding, T. N., Jankovic, L., Liu, C. & Wang, L. V., “Performance characterization of an integrated ultrasound, photoacoustic, and thermoacoustic imaging system,” J. Biomed. Opt. 17, 056010 (2012), Li, X., Heldermon, C. D., Yao, L., Xi, L. & Jiang, H., “High resolution functional photoacoustic tomography of breast cancer,”Med. Phys. 42, 5321-5328 (2015), which are hereby incorporated by reference in their entireties. These photoacoustic imaging systems may not meet the following requirements for breast imaging: (1) sufficient penetration depth to accommodate most breast sizes and skin colors, (2) high spatial resolution to reveal detailed angiographic structures, (3) high temporal resolution to minimize motion artifacts and enable dynamic or functional studies, (4) minimal limited-view artifacts, and (5) sufficient noise-equivalent sensitivity and contrast-to noise ratio to detect breast masses. Specifically, these photoacoustic imaging systems' have limitations mainly arising from their long scanning times and/or limited-view apertures (i.e., missing data or a<2π steradian solid angle).
For example, Toi and Kruger describe photoacoustic imaging systems that employ a hemispherical detector array and scan in a spiral pattern on a plane. Tumor detection with these systems was limited by respiratory motion artifacts resulting from long scanning time of about 4 minutes. Small tumor vessels, which often occur in small clusters were difficult to image with partial data and even more difficult to be coregistered with these systems. As anther example, others have planar transducer arrays and arc arrays for breast imaging. The limited views in these systems lowered their overall performance as discussed in Cox, B. T., Arridge, S. R. & Beard, P. C., “Photoacoustic tomography with a limited-aperture planar sensor and a reverberant cavity,” Inverse Probl. 23, S95-S112 (2007) and Huang, B., Xia, J., Maslov, K. & Wang, L. V., “Improving limited-view photoacoustic tomography with an acoustic reflector,” J. Biomed. Opt. 18, 110505 (2013), which are hereby incorporated by reference in their entireties. Consequently, most blood vessels were not well visualized in their images. The same problem occurred with linear transducer arrays, either fixed in position or scanned. One photoacoustic imaging system uses a ring-shaped array of 32 elements; however, however, the 32-element array generates a very limited field of view due to the sparse sampling. Accordingly, the system is not able to clearly reveal blood vessels in the breast as discussed in Li, L. et al., “Single-impulse panoramic photoacoustic computed tomography of small animal whole-body dynamics at high spatiotemporal resolution,” Nat. BME 1, 0071 (2017), which is hereby incorporated by reference in its entirety.
Certain aspects disclosed herein relate to PACT systems and methods. In certain implementations, PACT systems may be able to satisfy all the requirements for breast imaging discussed in Section I above. For example, in one implementation, a PACT system (i) combines 1064-nm light illumination and a 2.25-MHz unfocused ultrasonic transducer array to be able to achieve up to 4 cm in vivo imaging depth and a 255 μm in-plane resolution (approximately four times finer than that of contrast enhanced MRI. An example of MRI breast imaging is described in Lehman, C. D. & Schnall, M. D., “Imaging in breast cancer: magnetic resonance imaging,” Breast Cancer Res. 7, 215-219 (2005), which is hereby incorporated by reference in its entirety) to meet factors 1 and 2, (ii) is equipped with one-to-one mapped signal amplification and data acquisition (DAQ) circuits to be able to obtain an entire 2D cross-sectional breast image with a single laser pulse, or obtain a volumetric 3D image of the entire breast by fast elevational scanning within a single breath-hold (e.g., about 15 seconds) meeting factor 3, and (iii) has a 10 Hz 2D frame rate, currently limited by the laser repetition rate, allowing the system to observe biological dynamics in a cross-section associated with respiration and heartbeats without motion artifacts meeting factor 4, and (iv) includes a full-ring 512-element ultrasonic transducer array that enables the system to have a full-view fidelity in 2D imaging planes and delivers high image quality, meeting factor 5. Moreover, in certain implementations, a PACT system employs an illumination method and signal amplification that may be able to achieve sufficient noise-equivalent sensitivity that clearly reveal detailed angiographic structures both inside and outside breast tumors without the use of exogenous contrast agents.
The PACT system 100 also includes an ultrasonic transducer array 140 that can be coupled to or otherwise in acoustic communication with the specimen 130 to receive photoacoustic signals induced by the illumination. The PACT system 100 also includes one or more preamplifiers 150 and one or more data acquisition systems (DAQs) 160. The one or more pre-amplifiers 150 are in electrical communication with the ultrasonic transducer array 140 to receive a signal or signals. The DAQ(s) are in electrical communication with the pre-amplifier(s) 150 to receive a signal or signals. The PACT system 100 also includes a scanning mechanism 170 coupled to or otherwise operably connected to the ultrasonic transducer array 140, e.g., to move the ultrasonic transducer array 140 to one or more elevational positions and/or scan the ultrasonic transducer array 140 between two elevational positions. The PACT system 100 also includes a computing device 180 having one or more processors or other circuitry 182, a display 186 in electrical communication with the processor(s) 182, and a computer readable medium (CRM) 184 in electronic communication with the processor(s) 182. The computing device 180 is also in electronic communication with the light source(s) 110 to send control signals. The computing device 180 is in electrical communication with the DAQ(s) 160 to receive data transmissions and/or to send control signal(s). The computing device 180 is in electrical communication with the (DAQs) 160 to receive data transmissions. Optionally (denoted by dashed line), the computing device 180 is also in electronic communication with the one or more pre-amplifiers 150 to send control signal(s), e.g., to adjust the amplification. The electrical communication between system components of the PACT system 100 may be in wired and/or wireless form. The electrical communications may be able to provide power in addition to communicate signals in some cases.
In certain aspects, a PACT system includes a light source (e.g., a pulsed laser) that can generate pulsed or modulated illumination. In some cases, the light source is configured to generate pulsed or modulated light at a near-infrared wavelength or a narrow band of near-infrared wavelengths. For example, the light source may be a pulsed laser that can generate near infrared pulses having a wavelength or narrow band of wavelengths in a range from about 700 nm to about 1000 nm. As another example, the light source may be a pulsed laser that can generate near infrared pulses having a wavelength or narrow band of wavelengths in a range from about 600 nm to about 1100 nm. In yet another example, the light source may be a pulsed laser that can generate near infrared pulses with a wavelength or narrow band of wavelengths greater than 760 nm. In yet another example, the light source may be a pulsed laser that can generate near infrared pulses with a wavelength or narrow band of wavelengths greater than 1000 nm. In one implementation, the light source is a pulsed laser that can generate a 1064-nm laser beam. A commercially-available example of such as pulsed laser is the PRO-350-10, Quanta-Ray® laser with a 10-Hz pulse repetition rate and 8 ns-12 ns pulse width sold by Spectra-Physics®. The low optical attenuation of 1064 nm light or other near infrared light can be used to deeply penetrate (e.g., to a depth of 4 cm) biological tissues such as breast tissue. Imaging of biological tissues using near infrared light is discussed in Smith, A. M., Mancini, M. C. & Nie, S., “Bioimaging: second window for in vivo imaging,” Nat. Nanotechnol. 4, 710-711 (2009), which is hereby incorporated by reference in its entirety. Alternatively, the light source may be a continuous wave (CW) laser source that is chopped, modulated and/or gated to generate the pulsed or modulated illumination.
In implementations that have a light source in the form of a pulsed laser, the pulse repetition rate may be about 10-Hz in some cases, about 20-Hz in other cases, about 50-Hz in other cases, and about 100-Hz in other cases. In another aspect, the pulse repetition rate is in a range from about 10-Hz to about 100-Hz.
In one aspect, a light source of the PACT system is a tunable narrow-band pulsed laser such as, e.g., one of a quantum cascade laser, an interband cascade laser, an optical parametric oscillator, or other pulsed laser that can tuned to different narrow bands (e.g., near-infrared narrow bands of wavelengths). In other cases, the light source is a pulsed laser of a single wavelength or approximately a single wavelength.
In one aspect, the light source could be a combination of multiple same lasers. For example, multiple same lasers with a lower power for each of them. In another aspect, the light source could be a combination of multiple different lasers. For example, an optical parametric oscillator combined with an Nd:YAG laser.
An optical system of a PACT system includes one or more optical components (e.g., lens(es), optical filter(s), mirror(s), beam steering device(s), beam-splitter(s), optical fiber(s), relay(s), and/or beam combiner(s)) configured to propagate and/or alter light from a light source(s) to provide illumination to a specimen being imaged during operation. For example, the optical system may be configured to convert a light beam into shaped illumination such a donut beam that may be used, e.g., to circumferentially illuminate a human breast.
In one implementation, an optical system of a PACT system includes an axicon lens (e.g., an axicon lens having 25 mm diameter and a 160° apex angle) followed by an engineered diffuser (e.g., EDC-10-A-2s made by RPC Photonics) to convert a light beam into a donut beam. For example, the axicon lens may be positioned to receive a laser beam propagated from a pulsed laser source. The axicon lens can convert a single beam into a ring having a thickness and diameter and the engineered diffuser expands the ring into a donut beam. The donut beam may provide mass energy in homogenized, uniform illumination in deep tissue. An example donut-shaped illumination can be found in U.S. patent application Ser. No. 16/464,958, titled “SINGLE-IMPULSE PANORAMIC PHOTOACOUSTIC COMPUTED TOMOGRAPHY (SIP-PACT),” and filed on Nov. 29, 2017, which is hereby incorporated by reference in its entirety.
Compared to a Gaussian beam, a donut beam may be able to provide more uniform illumination inside a breast and also deposit less energy on a nipple and areola, which have a higher concentration of pigment. The illumination wavelength of 1064 nm is characterized by low optical attenuation within breast tissue, which can enable sufficient optical penetration in breast tissue for PACT imaging. A discussion of optical properties of biological tissues can be found in Jacques, S. L., “Optical properties of biological tissues: a review,” Phys. Med. Biol. 58, 5007-5008 (2013), which is hereby incorporated by reference in its entirety.
When evaluating one implementation of a PACT system with an axicon lens having a 25 mm diameter and 160° apex angle followed by an engineered diffuser (e.g., EDC-10-A-2s made by RPC Photonics), a laser beam was broadened into a donut shape with an outer diameter of about 10 cm, depositing light with an average laser fluence of about 20 mJ/cm2 on the breast surface. A laser fluence of 20 mJ/cm2 is about ⅕ of the safety limit for laser exposure as provided by the American National Standards Institute in its American national standard for the safe use of lasers ANSI z136.1-2007, Laser Institute of America, Orlando, Fla. (2007), which is hereby incorporated by reference in its entirety. This outer radius will cover many breasts and provides adequate SNR in breast images. Another implementation with a more energetic laser could enlarge the illumination area and increase the optical fluence to potentially improve sensitivity further in mass detection. The sensitivity of photoacoustic microscopy is discussed in Yao, J. & Wang, L. V., “Sensitivity of photoacoustic microscopy,” Photoacoustics 2, 87-101 (2014), which is hereby incorporated by reference in its entirety.
The ultrasonic transducer array (e.g., ultrasonic transducer array 140 in
In certain implementations, a full-ring ultrasonic transducer array is employed, e.g., to be able to provide 2D panoramic acoustic detection. The full-ring ultrasonic transducer array includes N transducer elements (e.g., 512-element full-ring ultrasonic transducer) distributed along the circumference of a ring having a diameter and an inter-element spacing. The ring diameter may be at least 220 mm in one aspect, may be at least 200 mm in one aspect, or may be at least 250 mm in one aspect. In one aspect, the ring diameter is in a range of about 150 mm to about 400 mm. The inter-element spacing may be less than or equal to about 1.0 mm in one aspect, less than or equal to 0.7 mm in one aspect, less than or equal to 1.5 mm in one aspect, or less than or equal to 2.0 mm in one aspect. In one aspect, the inter-element spacing is in a range of 0 mm to about 5 mm.
In one aspect, a full-ring ultrasonic transducer array with a ring of unfocused transducer elements is employed to sample both photoacoustic data at each laser pulse. An unfocused transducer element has a flared diffraction pattern with a diffraction angle of about 10 degrees as shown in
In certain aspects, donut-shaped optical illumination and panoramic acoustic detection are employed. The donut-shaped optical illumination and panoramic acoustic detection may provide uniform fluence distribution in deep tissue and in-plane coverage of ultrasound reception, respectively, delivering high image quality. Furthermore, considering the low cancer detection rate in mammography examinations (e.g., 0.41%), even though modern mammography uses a low dose of ionizing radiation, the risk-to-benefit ratio (e.g., 8%-17% for 40-50 year-old women) is considered high. The low cancer detection rate in mammography examinations is discussed in “Cancer Rate (per 1,000 examinations) and Cancer Detection Rate (per 1,000 examinations) for 1,838,372 Screening Mammography Examinations from 2004 to 2008 by Age —based on BCSC data through 2009,” NCI-funded Breast Cancer Surveillance Consortium (HHSN 261201100031C), which is hereby incorporated by reference. The risk-to-benefit ratios are discussed in Hendrick, R. E. & Tredennick, T., “Benefit to radiation risk of breast-specific gamma imaging compared with mammography in screening asymptomatic women with dense breasts,” Radiology 281, pp. 583-588 (2016) and Jung, H., “Assessment of usefulness and risk of mammography screening with exclusive attention to radiation risk,” Radiologe 41, 385-395 (2001), which are hereby incorporated by reference in their entirety. In comparison, the PACT system requires neither ionizing radiation nor an exogenous contrast agent, yielding zero risk.
In certain implementations, a PACT system includes a tank at least partially filed with acoustic medium such as a water tank (e.g., an acrylic water tank). The specimen being imaged may be located directly in the acoustic medium or in a portion of the tank that is submerged or otherwise located in the acoustic medium.
In certain implementations, a PACT system includes a specimen-receiving device for receiving and/or holding a specimen in place during the data acquisition phase. In one aspect, the specimen-receiving device includes a table or a patient bed and other components of the PACT system are located underneath the bed/table. In one aspect, the specimen-receiving device includes a housing for the ultrasonic transducer array where the ultrasonic transducer array is mounted on a stainless-steel rod (e.g., a rod having a 25 mm diameter) and is enclosed in a water tank.
Returning to
The PACT system 100 also includes one or more pre-amplifiers 150 and one or more data acquisition systems (DAQ) 160. The pre-amplifier(s) 150 is in electrical communication with the ultrasonic transducer array 140 to be able to receive photoacoustic signals. The pre-amplifier(s) 150 can boost the photoacoustic signals received from the ultrasonic transducer array 140. The DAQ(s) 160 is in electrical communication with the pre-amplifier(s) 150 to be able to receive photoacoustic signals. The DAQ(s) 160 can process the photoacoustic signals, for example, digitize the signals and/or record the photoacoustic signals. In certain aspects, the DAQ(s) 160 include at least one digitizer.
According to certain implementations, a PACT system acquires images at a high imaging speed or frame rate. The high imaging speed helps avoid respiration-induced motion artifacts when scanning the ultrasonic transducer array between elevational positions in a single breath hold data acquisition mode. The high imaging speed may also help enable detection of breast tumors by detailing tumor-associated angiogenesis in a single elevation data acquisition mode. The frame rate may be about 10-Hz in some cases, about 50-Hz in other cases, and about 30-Hz in other cases. In another example, the frame rate is in a range from about 10-Hz to about 20-Hz. In another example, the frame rate is in a range from about 20-Hz to about 100-Hz.
In certain implementations, a PACT system includes a set of one or more DAQ devices and a set of one or more pre-amplifiers that together provide one-to-one mapped associations with the number of transducers in the ultrasonic transducer array. These one-to-one mapped associations allow for fully parallelized data acquisition of all ultrasonic transducer channels and avoids the need for multiplexing after each laser pulse excitation. With one-to-one mapped associations between pre-amplifiers and transducer elements, each ultrasound transducer element in the array is in electrical communication with one dedicated pre-amplifier channel (also referred to as “preamp channel”). The one dedicated pre-amplifier channel is configured to amplify only photoacoustic signals detected by the one associated/mapped ultrasound transducer. These one-to-one mapped associations between the transducers and the pre-amplifier channels allow for parallelized pre-amplification of the photoacoustic signals detected by the plurality of transducers in the ultrasound transducer array. With one-to-one mapped analog-to-digital sampling, each pre-amplifier is operatively coupled to a corresponding dedicated data channel of an analog-to-digital sampling device in a DAQ to enable parallelized analog-to-digital sampling of the plurality of pre-amplified PA signals. The pre-amplified PA signals produced by each individual preamp channel are received by a single dedicated data channel of the at least one analog-to-digital sampling devices. Any suitable number of pre-amplifier devices and/or DAQ devices may be used to provide the one-to-one mapping. For example, a PACT system may include four 128-channel DAQs (e.g., SonixDAQ made by Ultrasonix Medical ULC with 40 MHz sampling rate, 12-bit dynamic range, and programmable amplification up to 51 dB) in communication with four 128-channel pre-amplifiers to provide simultaneous one-to-one mapped associations with a 512-element transducer array. This PACT system can acquire photoacoustic signals from a cross section within 100 μs without multiplexing after each laser pulse excitation. The plurality of pre-amplifier channels may be directly coupled to the corresponding plurality of ultrasound transducers or may be coupled with electrical connecting cables. In one aspect, wireless communication may be employed.
In certain aspects, the pre-amplifier gain of the pre-amplifier channels is selected based on factors such as, for example, signal-to-noise ratio, operating parameters of other data acquisition and processing system components such as analog-to-digital sampling devices (digitizers) of the DAQs, signal amplifiers, buffers, and computing devices. In one aspect, the pre-amplifier gain is in a range that is high enough to enable transmission of the photoacoustic signals with minimal signal contamination, but below a gain that may saturate the dynamic ranges of the data acquisition (DAQ) system used to digitize the photoacoustic signals amplified by the pre-amplifier(s). In certain aspects, the gain of the plurality of pre-amplifier channels may be at least about 5 dB, at least about 7 dB, at least about 9 dB, at least about 11 dB, at least about 13 dB, at least about 15 dB, at least about 17 dB, at least about 19 dB, at least about 21 dB, at least about 23 dB, at least about 25 dB, or at least about 30 dB.
Returning to
The processor(s) 182 executes instructions stored on the CRM 184 to perform one or more operations of the PACT system 100. In certain implementations, the processor(s) 182 and/or one or more external processors execute instructions to perform one or more of 1) determining and communicating control signals to system components, 2) performing reconstruction algorithm(s) reconstructing a 2D image and/or a 3D image of the specimen using photoacoustic signal data; and 3) performing techniques (e.g., tumor segmentation and elastographic technique) that can identify tumors using the 2D and/or 3D PACT images. For example, the processor(s) 182 and/or one or more external processors may execute instructions that communicate control signals to the scanning mechanism 170 to scan the ultrasonic transducer array 140 along a z-axis between to two elevations (3D mode) or move the ultrasonic transducer array 140 to one or more different elevations (2D mode) and send control signals to the digitizer in the DAQ(s) 160 to simultaneously record photoacoustic signals received by ultrasonic transducer array 140 from the illuminated regions of the specimen.
In some implementations, the PACT system includes one or more communication interfaces (e.g., a universal serial bus (USB) interface). Communication interfaces can be used, for example, to connect various peripherals and input/output (I/O) devices such as a wired keyboard or mouse or to connect a dongle for use in wirelessly connecting various wireless-enabled peripherals. Such additional interfaces also can include serial interfaces such as, for example, an interface to connect to a ribbon cable. It should also be appreciated that the various system components can be electrically coupled to communicate with various components over one or more of a variety of suitable interfaces and cables such as, for example, USB interfaces and cables, ribbon cables, Ethernet cables, among other suitable interfaces and cables.
In one aspect, the digitized radio frequency data from one or more DAQs (e.g., DAQs 160 in
Returning to
During operation, a 1064-nm laser beam from the light source 610 (e.g., PRO-350-10 made by Quanta-Ray with a 10-Hz pulse repetition rate and a 8-12-ns pulse width) is first reflected from the mirror 622, then passed through the axicon lens 624 (e.g., lab-polished axicon lens with 25 mm diameter and 160° apex angle), and then expanded by the engineered diffuser 626 (e.g., EDC-10-A-2s made by RPC Photonics) to form a donut-shaped light beam to circumferentially illuminate the breast 11. The laser fluence (e.g., 20 mJ/cm2) at the surface of the breast 11 in one example has been found to be within the American National Standards Institutes (ANSI) safety limit for laser exposure (i.e. 100 mJ/cm 2 at 1064 nm at a 10-Hz pulse repetition rate). In one aspect, to synchronize data acquisition with light pulses, the external trigger from the light source 610 may be used to trigger both the data acquisition systems 660 and the linear scanner 670.
The 512-element full-ring ultrasonic transducer array 640 (e.g., 512-element full-ring ultrasonic transducer array with 220 mm ring diameter and 2.25 MHz central frequency and more than 95% one-way bandwidth) is employed to provide 2D in-plane panoramic acoustic detection. Each transducer element had a flat-rectangular aperture (e.g., 5 mm element elevation size; 1.35 mm pitch; and 0.7 mm inter-element spacing). The ultrasonic transducer array housing was mounted on a stainless-steel rod (e.g., 25 mm diameter) and enclosed in the water tank 632. A linear scanner 670 (e.g., linear stage KR4610D made by THK America, Inc.) was fixed beneath the water tank 632 and moved the full-ring ultrasonic transducer array 640 elevationally via the stainless-steel rod. Four sets of 128-channel preamplifiers 650 (e.g., with 26 dB gain) were placed around the water tank 632, connected to the ultrasonic transducer array housing via signal cable bundles. Each set of preamplifiers 650 was further connected to a 128-channel data acquisition system 660 (e.g., SonixDAQ made by Ultrasonix Medical ULC with a 40 MHz sampling rate and 12-bit dynamic range) with programmable amplification up to 51 dB.
During operation of the PACT system 600 shown in
The fours sets of 128-channel data acquisition systems 660 provide simultaneous one-to-one mapped associations with the 512-element transducer array 640 to acquire photoacoustic signals from a cross section within 100 μs without multiplexing after each laser pulse excitation. The ultrasonic transducer elements may have a central frequency of 2.25 MHz and a one-way bandwidth of more than 95%, providing in-plane resolution of 255 μm. The height of each transducer element in the 512-element transducer array 640 yields a divergence angle in the elevational direction of about 9.0° full width at half maximum (FWHM)), yielding a flared diffraction pattern. This flared diffraction pattern enables both 2D imaging of a breast cross section per laser pulse and 3D imaging of the whole breast by scanning elevationally. The 3D back projection algorithm in Section III can be used to reconstruct a volumetric image with an elevational resolution of 5.6 mm, which is about 3 times finer than that given by the 2D reconstruction algorithm described in Section III.
It would be understood that in
The one or more pre-amplifiers 850 are in electrical communication with the ultrasonic transducer array 840 to receive a signal or signals and the DAQ(s) 860 are in electrical communication with the pre-amplifier(s) 850 to receive a signal or signals. The PACT system 800 also includes a linear scanner 870 coupled to or otherwise operably connected to the ultrasonic transducer array 840 to move the ultrasonic transducer array 840 to one or more elevational positions and/or scan the ultrasonic transducer array 840 between two elevational positions. The PACT system 800 also includes a computing device 880 having one or more processors or other circuitry and a computer readable medium (CRM) in electronic communication with the processor(s). The PACT system 800 also includes a controller 885 in electronic communication with the DAQ(s) 860 and the linear scanner 870 to send control signals. To synchronize the PACT system 800, the light source's external trigger is used to trigger both the DAQ(s) 860 and the linear scanner 870. The electrical communication between system components of the PACT system 800 may be in wired and/or wireless form. The electrical communications may be able to provide power in addition to communicate signals in some cases. During operation, the digitized radio frequency data is first stored in an onboard buffer, and then transferred to the computing device 880, e.g., through a universal serial bus 2.0. The DAQ(s) 860 are configured to record photoacoustic signals within a time period, e.g., 100 μs, after each laser pulse excitation.
Certain aspects pertain to implementations of PACT systems and methods that can integrate deep penetration into biological tissues and high spatiotemporal resolution. In some cases, these PACT systems and methods may have potential to be useful in breast cancer detection.
According to certain aspects, a PACT system is configured to be switchable between ( ) a two-dimensional (2D) mode; and (2) a three-dimensional ( 3D) mode.
At operation 910, the PACT system controls system components to perform data acquisition in a 2D mode or a 3D mode. Alternatively, data acquisition may be in both modes consecutively, e.g., in the 2D mode and then the 3D mode or in the 3D mode and then the 2D mode. The PACT system synchronizes data acquisition by the DAQ(s) and pre-amplifiers with the light pulses from the light source to acquire photoacoustic signals from the illuminated specimen. In one aspect, to synchronize data acquisition with light pulses, the external trigger from the light source may be used to trigger both the data acquisition systems and the scanning mechanism.
During data acquisition in the 2D mode, the ultrasonic transducer array is moved to one or more elevational positions (e.g., different locations z1, z2, z3, z4, etc. along a z-axis in
During acquisition in the 3D mode, the ultrasonic transducer array is scanned through multiple scanning steps between two elevational positions through a depth (e.g., through a depth between z1 and z2 locations along a z-axis in
The photoacoustic signals are recorded at a certain sampling frequency, which is determined by the data acquisition circuits. In one example, the sampling frequency is 40 MHz. In one aspect, the sampling frequency can be in a range from 4 MHz to 80 MHz. The time-domain photoacoustic signals acquired at all elevational scanning steps may then back-projected simultaneously into the 3D space. If tumor segmentation is going be performed operation 950, data acquisition in 3D mode may be conducted while the specimen is still to try to avoid any motion artifacts. For example, a human patient may be asked to hold their breathe during data acquisition.
At operation 920, the photoacoustic signals are received by the computing device from the DAQ(s). In some cases, the PACT system is equipped with a one-to-one mapped signal amplification and data acquisition (DAQ) systems or DAQ circuits to the transducer elements. In these cases, the PACT system can obtain photoacoustic signals for a 2D cross-sectional image with each laser pulse in 2D mode or obtain photoacoustic signals for a volumetric 3D image (e.g., of an entire breast) by fast elevational scanning within the time period such as, e.g., a single breath-hold (about 15 sec).
At operation 930, the photoacoustic signals are low-pass filtered with cut-off frequencies determined by the maximum distance from a point in the specimen being imaged to the transducer elements. For example, if a full-ring transducer array with 512 elements is used, the array can spatially sample objects within a field of view (FOV) of about 39 mm according to the spatial Nyquist criterion. To eliminate aliasing caused by under-sampling in regions outside of this FOV, the photoacoustic signals may be low-pass filtered with cut-off frequencies determined by the distance to the center of the ring array.
At operation 940, the PACT system performs image reconstruction to: 1) reconstruct a plurality of 2D images for each elevational position of the ultrasonic transducer array taken over a time period (2D mode) and/or 2) reconstruct a volumetric 3D image for the depth scanned by the ultrasonic transducer array ( 3D mode). In one aspect, a universal back-projection process can be used to reconstruct one or more 2D/3D images. An example of a universal back-projection process can be found in Xu, M. And Wang, L., “Universal back-projection algorithm for photoacoustic computed tomography,” Physical Review E 71, 016706 (2005), which is hereby incorporated by reference in its entirety. Another example of a back-projection process can be found in Anastasio, M. A. et al., “Half-time image reconstruction in thermoacoustic tomography,” IEEE Trans., Med. Imaging 24, pp 199-210 (2005), which is hereby incorporated by reference in its entirety. In another aspect, a dual-speed-of sound (dual-SOS) photoacoustic reconstruction process may be used. An example of a single-impulse panoramic photoacoustic computed tomography system that employs a dual-SOS photoacoustic reconstruction process is described in U.S patent application 2019/0307334, titled “SINGLE-IMPULSE PANORAMIC PHOTOACOUSTIC COMPUTED TOMOGRAPHY” and filed on May 29, 2019, which is hereby incorporated by reference in its entirety.
In one implementation, the half-time universal back-projection (UBP) process was used to reconstruct a volumetric 3D image and a 2D image of a breast using the PACT system 600 shown in
The 3D volumetric image is reconstructed with a particular voxel size in both the elevational direction and in the horizontal plane. An example of a suitable voxel size in the elevational direction is about 1 mm. An example of a suitable voxel size in the horizontal plane is 0.1 and 0.1 mm2. In some cases, one or more of the reconstructed images are batch processed to improve contrast. For example, a 3D volumetric image may be batch processed using vesselness filtering to improve contrast of blood vessels. An example of vesselness filtering that can be used is Hessian-based Frangi vesselness filtration described in Li, L. et al., “Single-impulse panoramic photoacoustic computed tomography of small animal whole body dynamics at high spatiotemporal resolution,” Nat. BME 1, 0071 (2017), which is hereby incorporated by reference in its entirety. In one implementation, e.g., in each horizontal slice of a 3D volumetric image, Hessian-based Frangi vesselness filtration was applied to enhance the contrast of blood vessels with diameters ranging from 3 to 12 pixels.
Returning to
In the 2D mode, the mass detection procedure includes performing an elastographic study (evaluation) on a plurality of 2D photoacoustic images. The high imaging speed of the PACT system allows for differentiation in compliance (or stiffness) between tumors and surrounding normal tissue. Tumors tend to be less compliant, deforming to a lesser extent, than surrounding normal tissue. The PACT method can differentiate between tumors and surrounding normal tissue by analyzing the differential compliance in the images taken at high speed of a cross-section. An example of operations in a mass detection procedure for this 2D mode is described in detail with reference to
In the 3D mode, the mass detection procedure includes tumor segmentation of a volumetric 3D image taken by the PACT system. An example of operations in a tumor detection procedure for the 3D mode is described with reference to
At operation 1210, photoacoustic signals are received, e.g., from the data acquisition systems. The photoacoustic signals are based on the photoacoustic array being at one location while photoacoustic waves are being detected. At operation 1220, a low-pass filter is applied to the photoacoustic signals to remove noise. For example, a low-pass filter of 4.5 MhZ may be used. For a pixel and an element location, the time delay is calculated at operation 1230. At operation 1240, an acquired signal at the calculated time delay is used to calculate the back-projection term and this is added to the pixel value. At operation 1260, the process returns to repeat operations 1230 and 1240 for all combinations of pixel and element locations. At operation 1250, a 2D image is formed of all the pixel values.
A similar set of operations is depicted for reconstructing a 3D image. That is, at operation 1210, photoacoustic signals are received, e.g., from the data acquisition systems. In this case, the photoacoustic signals are based on the photoacoustic array being scanned between two positions while photoacoustic waves are being detected. At operation 1220, a low-pass filter is applied to the photoacoustic signals to remove noise. For example, a low-pass filter of 4.5 MhZ may be used. For a voxel and an element location, the calculated time delay is calculated at operation 1230. At operation 1240, an acquired signal at the time delay is used to calculate the back-projection term and this is added to the voxel value. At operation 1260, the process returns to repeat operations 1230 and 1240 for all combinations of voxel and element locations. At operation 1250, a 3D image is formed of all the voxel values.
In
Certain aspects pertain to methods that may be used to identify masses of interest in, e.g., biological tissues, using either a plurality of 2D images of a cross section or a volumetric 3D image. For example, one aspect pertains to methods that may be used to identify masses using elastographic measurements from a plurality of 2D images of a particular cross-section acquired at high speed over a period of time. As another example, another aspect pertains to a method of identifying masses using a quantified density of blood vessels counted in regions of a volumetric 3D image.
One aspect pertains to a PACT method that uses a plurality of 2D images reconstructed from photoacoustic signals recorded at high imaging speed (e.g., at or above 10 Hz frame rate) at each of one or more cross-sections (depths). During data acquisition, a plurality of 2D images is acquired at high speed at each of the depths while the specimen is allowed to deform (e.g., small deformations less than or equal to 1 cm). For example, a patient may breathe normally while photoacoustic signals are recorded while an ultrasonic transducer array of the PACT system 600 in
Another aspect pertains to a PACT method that uses a volumetric 3D image reconstructed from photoacoustic signals recorded while the specimen remains still and the ultrasonic transducer array scans through the depth. For example, in the 3D data acquisition mode, patients may hold their breath while photoacoustic signals are recorded as during a scan of a human breast from the breast wall to the nipple. As the principal optical absorber in the near infrared region, hemoglobin provides an endogenous contrast for imaging of blood vessels. A high density of blood vessels tends to correlate with angiogenesis, which may play an important role in tumor growth and metastasis. This second PACT method includes an automated segmentation process that extracts a vessel skeleton from the volumetric 3D image, produces a vessel density (number of vessels/area) map of the biological tissue such as a breast and then highlights a region with highest vessel density as a mass of interest. Due to angiogenesis in tumor regions, this second PACT method may be used to show masses of interest by revealing a greater density of blood vessels in certain regions.
At operation 1010, to assess deformations over time, the first 2D image (frame) is taken as a reference and a batch of points (pixels) is randomly picked from the first 2D image.
At operation 1020, movement of the batch of points is tracked using a tracking process that registers the other frames with the first frame. An example of a tracking process is a non-rigid demon process, e.g., the non-rigid demon function in Matlab. An example of a tracking process is also described in Thirion, J P., “Image matching as a diffusion process: an analogy with Maxwell's demons,”Med. Image Anal. 2, 243-260 (1998), which is hereby incorporated by reference in its entirety. The non-rigid demon process defines a feature around each point in the batch of points to determine its movement. For each point of the registered frames, the standard deviation (STD) of the value variations was calculated. Points with relatively small STDs (e.g., less than a maximum allowable STD) were stably registered and were used for deformation quantification. The other points with large STDs were removed. An example of a maximum allowable STD is 0.18.
At operation 1030, the movement of the batch of points is analyzed in the frequency domain and the high frequency movements, which are generally not due to breathing, are removed by low-pass filtering. The frequency component due to deformation from breathing is in a range of 0.2-0.5 Hz. The small and/or high frequency movements are removed by filtering so that mainly movements due to breathing are being monitored. At operations 1020 and 1030, small and/or high frequency movements are removed so that movements due to breathing with larger and lower frequency are being monitored.
At operation 1040, a triangular grid for the batch of points is generated to be able to track deformation of areas. The triangular grid includes a plurality of triangles formed from the batch of points. In some cases, the triangles may share points. The triangular grid is mapped back to the unregistered frames and their triangular areas (areas of the triangles) are calculated. In one case, the triangle grid may be generated, for example, using a Matlab function. The entire image was then segmented into 2 mm×2 mm squares. One stably registered pixel was chosen from each square, and triangular grids were further generated from these registered pixels.
At operation 1050, the deformation based on changes to the areas of the triangles in the triangular grid is calculated. The tracked movement of the points of each triangle is used to determine the deformation of the area of each triangle in the triangular grid.
At operation 1060, a deformation map for each batch of points is determined. The deformation map includes the changes in area of each of the triangles. For each triangle, Fourier transformation was applied to quantify the area variation at the frequency of periodic compression, and amplitudes were assigned to the points of the triangle to generate the deformations for the deformation map. For example, the amplitude of the deformation of each triangle may be mapped to the points of the triangle to generate the deformation map.
At operation 1085, the process returns to repeat operations 1010, 1020, 1030, 1040, 1050, and 1060 for B batches of points where B is the number of batches of points (e.g., B may be 100).
After operations 1010, 1020, 1030, 1040, 1050, and 1060 have been completed for each of the batches of points to determine a plurality of B deformation maps, an average of the plurality of deformation maps is calculated to determine a final elastogram (operation 1070). For example, at operation 1070, the average deformation for all the deformation maps may be determined for each point in the batches of points and mapped to that point to determine a final elastogram.
At operation 1080, the final elastogram is evaluated to identify any region at the cross section with a potential mass. For example, deformation at different points in the elastogram may be evaluated to determine whether the deformation at any of the points is below a threshold value. The location of the point that is below a threshold value may be determined to be in a region potentially having a mass. An example of a threshold value is 0.036. Another example of a threshold value is 0.048. As another example, if the deformations of multiple neighboring points are below a threshold value, it may be determined that potentially there is a mass in the region of the neighboring points.
At operation 1090, the process repeats for each additional cross-section for S cross-sections (e.g., S=3, 4, 5, or 6). For example, if photoacoustic signals are acquired for each of four cross-sections at four depths (e.g., for depths separated by 1 cm, which is less than the elevational resolution in 2D for the ultrasonic transducer array), then the process will repeat four times. Alternatively, the process will be performed for all cross sections in parallel. If only one cross-section is being evaluated, the process is performed once and operation 1090 can be omitted.
At operation 1110, the maximum amplitude projection (MAP) is determined at each pixel of the volumetric 3D image. First, the nipple layers of the volumetric 3D are removed. Each voxel at different depths of the volumetric 3D image is evaluated to determine the voxel with the maximum amplitude. The voxels with maximum amplitude are projected to a plane to generate a MAP.
At operation 1120, vessel segmentation is performed on the 3D volumetric image using vesselness filtering and thresholding. The vesselness filtering process can improve contrast of any blood vessels in the 3D image. In one implementation, in each horizontal slice, a vesselness filtering process is applied in each horizontal slice of the 3D volumetric image. An example of vesselness filtering process that can be used is Hessian-based Frangi vesselness filtration. Hessian-based Frangi vesselness filtration is described in Li, L. et al., “Single-impulse panoramic photoacoustic computed tomography of small animal whole body dynamics at high spatiotemporal resolution,” Nat. BME 1, 0071 (2017), which is hereby incorporated by reference in its entirety. For example, in each horizontal slice of the 3D volumetric image, the vesselness filtration process may be applied to enhance the contrast of blood vessels with diameters ranging from 3 to 12 pixels. In this example, the voxel has a size of 1 mm in the elevational direction and 0.1×0.1 mm2 on the horizontal plane. After the vesselness filtering process is applied, adaptive thresholding is used for each filtered horizontal slice to segment blood vessels. An example of counting blood vessels is described in Tsai, P. S. et al., “Correlations of neuronal and microvascular densities in murine cortex revealed by direct counting and colocalization of nuclei and vessels,” J. Neurosci. 29, 14553-14570 (2009), which is hereby incorporated by reference in its entirety.
At operation 1130, a vessel skeleton is extracted. The vessel skeleton includes all the vessels segmented in operation 1120. In the vessel skeleton, the vessels have been turned into lines. For example, a vessel skeleton may be extracted by using morphology filtration for single-pixel elimination.
At operation 1140, the vessels in a moving window are counted for each window position to determine vessel numbers for each window in the MAP of a 3D image. An example of the window size is 15×15 pixels. Another example of the window size is 20×20 pixels. Other window sizes would be contemplated. In one example, the window movement may be two pixels in one direction for each window position. In another example, the window movement may be three pixels in one direction for each window position.
At operation 1150, a vessel density map is determined. At each window position, the density is calculated using the numbers of vessels counted at each window position and the area of the corresponding window. The density map includes the calculated densities for different pixel locations at the window positions across each horizontal slice in the 2D MAP image.
At operation 1160, one or more regions with high vessel density are located. For example, a threshold vessel density value may be calculated and any pixels with vessel density greater than the threshold vessel density value may be determined to have a high vessel density. In one implementation, the threshold vessel density value may be a set value. In one example, the threshold vessel density value is in the range of whole-breast's average plus 1.0 time the standard deviation to 2.0 times the standard deviation. In another example, the threshold vessel density value is above whole-breast's average plus 2.0 times the standard deviation. In one implementation, the vessel density value is set by an operator. In another implementation, the vessel density value is calculated from a maximum vessel density in the 3D volumetric image. For example, a threshold vessel density value may be 90% of the maximum vessel density in the 3D volumetric image. These regions may be designated as potential masses of interest in one implementation.
In one embodiment, the process described with reference to
In one embodiment, the process described with reference to
Two exemplary PACT methods that can be used to identify one or more regions of potential masses that may be breast tumors in angiographic photoacoustic computed tomography (PACT) images are provided below. In Section IV, evaluation data from employing examples of these two methods to image seven breast cancer patients has been provided. In the evaluation case, the ability to detect tumors was demonstrated via blood vessel density using a PACT method with automated tumor segmentation in eight of nine cases, and using a PACT method with elastography to detect differences in the stiffness of the tissue in the remaining case.
Certain implementations of PACT methods employ an automatic tumor segmentation technique that may make it easier to recognize a tumor by highlighting a region with high vessel density. Due to angiogenesis in tumor regions, PACT images may be used to identify breast masses by revealing a greater density of blood vessels. To segment tumors automatically, a vessel skeleton may be extracted and a vessel density (number of vessels/area) map of the breast determined. The regions with the highest vessel density highlight regions with potential breast masses.
High speed imaging such as available with PACT systems enables capturing images that can be used to differentiate compliance between tumors and surrounding normal breast tissue, providing another contrast for detecting breast cancer. During image acquisition, patients are asked to breathe normally. The chest wall pushed the breast against the agar pillow, elevationally generating a deformation of the breast in the coronal plane. The change of area at different points are determined. Tumors, being stiffer, could be identified in areas with less deformation than normal breast tissue.
The American Cancer Society recommends regular examinations of breast lesions as the best way to detect breast cancers early. The automatic tumor segmentation technique of certain implementations may make it easier to recognize tumors by highlighting a region with high vessel density. In addition, the high 2D imaging speed (e.g., 10 Hz frame rate) of certain implementations of PACT systems can enable performing elastographic measurements and further improve on breast cancer detection. Moreover, PACT systems are different from mammography in that PACT systems do not implement ionizing radiation and do not have the limitations in radiographically dense breasts. As compared to MRI, PACT systems do not use exogenous contrast agents and can scan an entire breast within a single breath hold of about 15 seconds.
The non-limiting examples provided in Section IV are to further illustrate certain implementations of PACT techniques. It would be appreciated that certain techniques implemented in these examples represent approaches for PACT systems and methods that have been found to function well, and thus can be considered to constitute examples of modes for their practice. However, those of skill in the art should, in light of the present disclosure, appreciate that many changes can be made in the specific examples that are disclosed and still obtain a like or similar result without departing from the spirit and scope of the present disclosure.
An example of a PACT system was used to image the breasts of one healthy volunteer and seven breast cancer patients. The PACT system included an illumination (light) laser source, an ultrasonic transducer array, signal amplification/acquisition modules, a linear scanning stage, and a patient bed similar to the PACT system 600 described with reference to
To achieve 2D panoramic acoustic detection, a 512-element, full-ring ultrasonic transducer array (e.g., Imasonic, Inc.; 220 mm ring diameter; 2.25 MHz central frequency; more than 95% one-way bandwidth) was used. The transducer elements were unfocused and had a central frequency of 2.25 MHz and a one-way bandwidth of more than 95%. Each transducer element had a flat-rectangular aperture (5 mm element elevation size; 1.35 mm pitch; 0.7 mm inter-element spacing). The ultrasonic transducer array housing was mounted on a stainless-steel rod (25 mm diameter) and enclosed in an acrylic water tank. A linear stage (e.g., THK America, Inc., KR 4610D) was fixed beneath the water tank and moved the transducer array elevationally via the stainless-steel rod. The ultrasonic transducer array had an in-plane resolution of 255 μm as described in
Four sets of 128-channel preamplifiers (26 dB gain) were placed around the water tank, connected to the ultrasonic array housing via signal cable bundles. Each set of preamplifiers was further connected to a 128-channel data acquisition system (e.g., SonixDAQ, Ultrasonix Medical ULC; 40 MHz sampling rate; 12 -bit dynamic range) with programmable amplification up to 51 dB. The digitized radio frequency data were first stored in an onboard buffer, and then transferred to a computer through a universal serial bus 2.0. The data acquisition systems were set to record PA signals within 100 μs after each laser pulse excitation. This PACT system was equipped with four sets of 128-channel data acquisition systems to provide simultaneous one-to-one mapped associations with the 512-element transducer array. Therefore, photoacoustic signals were acquired from a cross-section within 100 μs without multiplexing after each laser pulse excitation.
During the data acquisition phase, the patient being imaged was positioned prone with one breast dependent and placed into a large aperture in the bed such as the patient bed 15 shown in
A PACT method of an implementation employed a half-time universal back-projection (UBP) process to reconstruct a 3D volumetric image and a plurality of 2D images of a cross-section acquired over a time period. An example of a half-time UBP process can be found in Anastasio, M. A. et al., “Half-time image reconstruction in thermoacoustic tomography,” IEEE Trans. Med. Imaging 24, 199-210 (2005), which is hereby incorporated by reference in its entirety. In 2D imaging mode, the time-domain photoacoustic signals generated by each laser pulse were back-projected to a 2D imaging plane. Determined by the acoustic divergence angle (about) 9.0° at FWHM in the elevational direction discussed in
The full-ring transducer array with 512 elements could spatially well sample objects—according to the spatial Nyquist criterion—within a field of view (FOV) of about 39 mm in diameter. To eliminate aliasing caused by under-sampling in regions outside of this FOV, the photoacoustic signals were low-pass filtered with cut-off frequencies determined by the distance to the center of the ring array.
Using an implementation of a PACT method, each volumetric image was reconstructed with a voxel size of 1 mm in the elevational direction and 0.1×0.1 mm2 on the horizontal plane. The reconstructed images were batch-processed all to improve contrast. In each horizontal slice, a Hessian-based Frangi vesselness filtration process was used to enhance the contrast of blood vessels with diameters ranging from 3 to 12 pixels. In each filtered slice, adaptive thresholding was used to segment blood vessels, followed by morphology filtration for single-pixel elimination. In the elevational direction of each filtered volumetric image, voxels were selected with the largest PA amplitudes and then projected their depths to form a 2D image. A median filtration was applied with a window size of 3×3 pixels to the depth image. Another median filtration with a window size of 6×6 pixels was further applied inside the segmented vessels to the segmented vessels' depths. Different RGB (red, green, blue) color values were assigned to discrete depths. Finally, the 2D depth-resolved color-encoded image was multiplied by the MAP image pixel by pixel to represent the maximum amplitudes. To further reduce noise and improve image quality, the above parameters in 2D slices were tuned at different depths, which resulted in the custom processing images in
A PACT method of one implementation was used to measure vascular diameters by identifying vessel boundaries through a correlation-based template matching process. The templates were generated through simulation. The impulse responses of all ultrasonic transducers were used to simulate the images of vessels with different sizes (0.5-2.0 mm) and orientations. The diameters of vessels chosen from the PACT breast images were quantified by matching the reconstructed vessel images with the generated templates.
To separate fluctuations caused only by heart beats, frames with strong motion caused by body movement were first removed. The entire imaging field was then divided into 16 slightly overlapping subdomains. In each subdomain, the first frame was selected as the reference frame. The other frames were registered to it through rigid transformation, optimizing the frame-frame correlation. In each subdomain, a Gaussian filter with a radius of 0.2 mm was applied to all registered frames to reduce high spatial-frequency noise. A Fourier transformation was applied to each pixel's value through all the frames. The fluctuations in pixel values induced by arterial pulse propagation were quantified within the frequency range (1.0-1.6 Hz) of heartbeat cycles. The frequency range (1.0-1.6 Hz) of heartbeat cycles can be found in Bender, L., “Human Body” Crescent Books, New York, (1992).
A PACT method, of one implementation, was used to identify breast masses by revealing a greater density of blood vessels, presumably due to angiogenesis, in tumor regions. To segment tumors automatically, the vessel skeleton was extracted and a vessel density (number of vessels/area) map of the breast was produced. The regions with the highest vessel density highlighted the breast mass of interest. The dense vessels in the nipple would affect the automatic tumor segmentation. Therefore, the shallowest slices containing the nipple were first removed. The remaining slices were used to generate the MAP image. A vessel mask was generated from the MAP by Hessian filtering and threshold-based segmentation. Based on the mask, vessel centerlines were extracted by removing boundary pixels. The vessel centerlines were broken into independent vessels at junction points.
To further reduce noise, the independent vessels with lengths less than 3 pixels (255-μm spatial resolution divided by 100-μm pixel size is approximately 3) were removed. A 2 mm×2 mm window was then used to scan the entire image. At each scanning location, the number of vessels (independent segments) inside the window was counted and assigned to the center pixel in the window. The vessel density was quantified as the number of vessels divided by the window area.
To demarcate breast tumors from MAP images, suspicious regions were first identified where blood vessel densities were higher than a threshold, which was set to each whole-breast's average plus 2.0 times the standard deviation. The number of pixels was counted in each contiguous region and the regions with pixel counts fewer than 1855 (18.55 mm2) were rejected to eliminate false positive cases. The remaining contiguous regions were labeled as tumors.
In a PACT method according to one implementation, the high imaging speed enabled differentiation in compliance between tumors and surrounding normal breast tissue, providing another contrast for detecting breast cancer. First, elastographic measurements were performed on a breast phantom as a test case. The phantom comprised a ball with 7% agar (mimicking breast tumor) embedded in a base of 2% agar (mimicking normal breast tissue). A discussion of breast tissue stiffness is described in Wellman, P. S., Howe, R. D., Dalton, E. & Kern, K. A., “Breast tissue stiffness in compression is correlated to histological diagnosis,” Technical Report. Harvard BioRobotics Laboratory, 1-15 (1999), which is hereby incorporated by reference in its entirety. Chopped human hair was uniformly distributed in the phantom to mimic small blood vessels. Working in 2D imaging mode, the PACT method quantified the relative area changes in a cross section when minor deformations were induced by periodic compressions (about 0.25 Hz) on top of the phantom. Due to the low elevational sectioning power of 2D imaging, objects in 2D frames were mainly influenced by coronal dilation instead of elevational displacement. Accordingly, the PACT elastography clearly revealed the agar ball with correct size and location as shown in
To assess deformations over time, the first frame was taken as a reference. Other frames were registered to the first frame through a non-rigid demon algorithm in Matlab. An example of imaging matching can be found in Thirion, J P., “Image matching as a diffusion process: an analogy with Maxwell's demons,” Med. Image Anal. 2, 243-260 (1998), which is hereby incorporated by reference in its entirety. For each pixel of registered frames, the standard deviation (STD) of the value variations was calculated. Pixels with relatively small STDs were stably registered and were used for deformation quantification. The entire image was then segmented into 2 mm×2 mm squares. One stably registered pixel was chosen from each square, and triangular grids were further generated from these registered pixels. The triangular grids were mapped back to the original unregistered frames, and their areas were calculated. For each grid, Fourier transformation was applied to quantify the area variation at the frequency of periodic compression, and amplitudes were assigned to the pixels inside this triangle to generate the deformation map. To further reduce noise, 100 deformation maps were generated with randomly registered pixels in the squares. The final image is the average of the 100 deformation maps.
To conduct SHB-PACT elastography of the breast, patients were asked to breathe normally. The chest wall pushed the breast against the agar pillow, elevationally generating a deformation of the breast in the coronal plane. The same method was used to quantify the change of area between blood vessels in the breast. Tumors, being stiffer, could be identified in areas with less deformation than normal breast tissue.
The PACT system described in Section IV(A) was used to identify eight of nine breast tumors by delineation of angiographic anatomy in the 3D image. These tumors were subsequently verified by ultrasound-guided biopsy. The automated tumor segmentation technique was used to highlight the tumors automatically. Tumors were clearly revealed by PACT techniques in all breasts even in radiographically dense breasts, which could not be readily imaged by mammography. Taking advantage of the high imaging speed, PACT techniques were implemented to take elastographic measurements of 2D images to detect tumors by assessing deformations caused by breathing. The elastography measurements identified the one tumor missed in angiographic imaging, and thus improved the sensitivity of tumor detection. At such high spatiotemporal resolutions, the PACT system was able to differentiate arteries from veins by detecting blood flow mediated arterial deformation at the heartbeat frequency.
Before imaging breast cancer patients, the performance of the PACT system was assessed by imaging a 27-year-old healthy female volunteer. By scanning the transducer array elevationally through her right breast, within one breath hold (about 15 seconds), the angiographic anatomy was revealed from the nipple to the chest wall.
To measure the vascular diameters, vessel boundaries were identified in different slices through a correlation-based template matching technique such as, e.g., described in Tsai, P. S. et al., “Correlations of neuronal and microvascular densities in murine cortex revealed by direct counting and colocalization of nuclei and vessels,” J. Neurosci. 29, 14553-14570 (2009), which is hereby incorporated by reference in its entirety.
By measuring vascular diameters, the relationship between parent and daughter vessels at vascular bifurcations was further investigated, which is expressed by the junction exponent. Diameter relationships at vascular bifurcations is discussed in Witt, N. W. et al., “A novel measure to characterise optimality of diameter relationships at retinal vascular bifurcations,” Artery Res. 4, 75-80 (2010), which is hereby incorporated by reference in its entirety. A vessel tree was selected in the breast and marked five branch levels with distinct colors.
During a breath hold within 10 seconds, a cross section of the contralateral healthy breast in one of the breast cancer patients was imaged with the PACT system. Working in 2D mode at a 10 Hz frame rate, the PACT system continuously monitored arterial pulsatile deformation inside the breast by fixing the transducer array at a specific elevational position. An example of mechanotransduction can be found in Davies, P. F., “Flow-mediated endothelial mechanotransduction,”Physiol. Rev. 75, 519-560 (1995), which is hereby incorporated by reference in its entirety. The photoacoustic signals were analyzed pixel-wise in the frequency domain to identify arteries and veins according to the heartbeat frequency. Photoacoustic signals were analyzed pixel-wise in the frequency domain to identify arteries and veins according to the heartbeat frequency.
The breasts of seven breast cancer patients, having breast sizes ranging from B cup to DD cup (over 99% of the U.S. population has breast sizes of DD cup or smaller according to “Average Breast Size” <<TheAverageBody.com>> (2015)) and skin pigmentations ranging from light to dark were imaged using the PACT system.
Angiogenesis, which plays a central role in breast cancer development, invasion, and metastasis, is the essential hallmark by which PACT techniques may be able to differentiate lesions from normal breast tissue. Well correlated with the tumor locations shown in mammograms and reported by ultrasound-guided biopsy, the PACT images in
The PACT method with tumor segmentation may be used to distinguish tumors automatically, which may be beneficial in a clinical setting. Presumably due to angiogenesis, tumors appear as regions of denser blood vessels in PACT images. When implementing the PACT method to segment tumors automatically, the vessel skeleton was extracted and a vessel density map was produced of the breast (local vessel number/local area). The regions with the highest vessel density highlight the breast tumors as shown in column (d) of
In addition to direct observation of blood vessel density, the PACT system detected the difference in compliance between tumors and surrounding normal breast tissue, providing an alternate concurrent contrast to detect breast cancer. Before performing elastography on breast cancer patients, this PACT method was used to image breast-mimicking phantoms.
During an evaluation, a PACT system was used to identify eight of the nine biopsy-verified tumors by assessing blood vessel density. Moreover, the initially undetected tumor was subsequently revealed by elastographic SBH-PACT. Pathology reports showed two benign tumors (Patient 5, stromal fibrosis or fibroadenoma; Patient 7, right, fibroadenoma), one ductal carcinoma in situ (DCIS) with a 3/3 nuclear grade (Patient 2), and six invasive carcinomas (all other cases). Angiogenesis serves as a basis for tumor identification. Considering the diversity among the subjects, high blood vessel densities were defined as values greater than the whole-breast average plus (a) 1.5, (b) 2.0, or (c) 2.5 times the standard deviation, respectively. The ratios of average vessel density were calculated and compared between the high-density region and the normal density region in each affected and contralateral breasts shown in
The tumors were then demarcated in each breast and the average vessel densities inside and outside the tumors were computed using one or more methods described in Section III. The average vessel density ratios between the tumors and the surrounding normal breast tissues were 3.4±0.99.
Since the elastography study began with Patient 4, PACT elastography identified all five tumors in the subsequent four patients.
In certain cases, the laser beam was broadened into a donut shape with an outer diameter of about 10 cm, depositing light with an average laser fluence of about 20 mJ/cm2 on the breast surface (which is about ⅕ of the American National Standards Institutes safety limit). This outer radius covered most breasts and provided satisfactory SNR in breast images. Merely assessing blood vessel density, one tumor located in an insufficiently illuminated marginal region of a D cup breast was not detected (P7(L) in column (a) of
In certain aspects, a PACT method includes an automatic tumor segmentation algorithm that may make it easier to recognize tumors by highlighting the suspicious affected region with the highest vessel density. In addition, the high 2D imaging speed of PACT techniques (e.g., 10 Hz frame rate) enabled the performance of elastographic measurements that may help improve breast cancer detection. The capability of PACT techniques to map arterial distribution can potentially be useful in diagnosing artery-related diseases. Discussions related to artery-related diseases can be found in Caplan, L. R., “Carotid-artery disease,” N. Engl. J. Med. 315, 886-888 ( 196), Libby, P., Ridker, P. M. & Maseri, A., “Inflammation and atherosclerosis,” Circulation 105, 1135-1143, (2002), and Ouriel, K., “Peripheral arterial disease,” Lancet 358, 1257-1264 (2005), which are hereby incorporated by reference in their entireties. In addition, the knowledge of vessel diameters and average PA signals from arteries can be used to calibrate the local optical fluence, thus providing accurate spectral sO2 measurement in deep tissue.
The PACT techniques may provide a tool for future clinical use including not only screening, but also diagnostic studies to determine extent of disease, to assist in surgical treatment planning, and to assess responses to neoadjuvant chemotherapy. Compared to mammography, PACT techniques utilize non-ionizing radiation, show promise for sensitivity in radiographically dense breasts, and impose less or no pain by only slightly compressing the breast against the chest wall. Because the average hemoglobin concentration in malignant tumors is generally twice that in benign tumors, PACT techniques may have the potential to distinguish malignant tumors from benign tumors by quantifying blood vessel densities in the tumor. For example, one implementation of a PACT system was used to compare malignant and benign tumors by comparing vessel density ratio. The results are shown in
The PACT imaging in this section was performed after a standard of care (SOC) work-up, but in advance of percutaneous biopsy. This order of events was designed to minimize confounding imaging findings related to biopsy-induced hemorrhage. Patients underwent only one PACT imaging study, which took less than 10 minutes. Both the contralateral and affected breasts were imaged. For the abnormal breast, the tumor size, tumor depth, blood vessel density, and signal amplitude in the breast images were analyzed. The analysis of tumor size/depth was further compared with the standard imaging results (mammography and ultrasonography). To identify the tumor types and grades, histopathology results from the SOC biopsy were used as the ground truth for interpretation of the results.
Using established clinical protocols, abnormalities were identified either through routine screening mammography, or diagnostic evaluation in symptomatic patients. Pre-biopsy work up included combinations of digital mammography, digital breast tomosynthesis, and ultrasound. Formal BI-RADS (breast imaging, reporting and data system) assessments were assigned in all cases, with appropriate recommendation for biopsy. Image-guided percutaneous biopsy was obtained using real-time ultrasound guidance and a 12-guage or 14-guage spring-loaded biopsy needle (chosen at the discretion of the performing physician.). Core specimens were submitted in formalin to the pathology department for histologic analysis as per normal routine at the institution. All cases were reviewed following receipt of the final pathology report to determine radiologic-pathologic correlation. Some patients underwent contrast enhanced breast MRI following confirmation of malignancy.
Modifications, additions, or omissions may be made to any of the above-described embodiments without departing from the scope of the disclosure. Any of the embodiments described above may include more, fewer, or other features without departing from the scope of the disclosure. Additionally, the steps of described features may be performed in any suitable order without departing from the scope of the disclosure. Also, one or more features from any embodiment may be combined with one or more features of any other embodiment without departing from the scope of the disclosure. The components of any embodiment may be integrated or separated according to particular needs without departing from the scope of the disclosure. For example, it would be understood that while certain PACT systems are described herein with a linear stage, another mechanism may be used.
It should be understood that certain aspects described above can be implemented in the form of logic using computer software in a modular or integrated manner. Based on the disclosure and teachings provided herein, a person of ordinary skill in the art will know and appreciate other ways and/or methods to implement the present invention using hardware and a combination of hardware and software.
Any of the software components or functions described in this application, may be implemented as software code using any suitable computer language and/or computational software such as, for example, Java, C, C#, C++ or Python, LabVIEW, Mathematica, or other suitable language/computational software, including low level code, including code written for field programmable gate arrays, for example in VHDL. The code may include software libraries for functions like data acquisition and control, motion control, image acquisition and display, etc. Some or all of the code may also run on a personal computer, single board computer, embedded controller, microcontroller, digital signal processor, field programmable gate array and/or any combination thereof or any similar computation device and/or logic device(s). The software code may be stored as a series of instructions, or commands on a CRM such as a random access memory (RAM), a read only memory (ROM), a magnetic medium such as a hard-drive or a floppy disk, or an optical medium such as a CD-ROM, or solid stage storage such as a solid state hard drive or removable flash memory device or any suitable storage device. Any such CRM may reside on or within a single computational apparatus, and may be present on or within different computational apparatuses within a system or network. Although the foregoing disclosed embodiments have been described in some detail to facilitate understanding, the described embodiments are to be considered illustrative and not limiting. It will be apparent to one of ordinary skill in the art that certain changes and modifications can be practiced within the scope of the appended claims.
The terms “comprise,” “have” and “include” are open-ended linking verbs. Any forms or tenses of one or more of these verbs, such as “comprises,” “comprising,” “has,” “having,” “includes” and “including,” are also open-ended. For example, any method that “comprises,” “has” or “includes” one or more steps is not limited to possessing only those one or more steps and can also cover other unlisted steps. Similarly, any composition or device that “comprises,” “has” or “includes” one or more features is not limited to possessing only those one or more features and can cover other unlisted features.
All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g. “such as”) provided with respect to certain embodiments herein is intended merely to better illuminate the present disclosure and does not pose a limitation on the scope of the present disclosure otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the present disclosure.
Groupings of alternative elements or embodiments of the present disclosure disclosed herein are not to be construed as limitations. Each group member can be referred to and claimed individually or in any combination with other members of the group or other elements found herein. One or more members of a group can be included in, or deleted from, a group for reasons of convenience or patentability. When any such inclusion or deletion occurs, the specification is herein deemed to contain the group as modified thus fulfilling the written description of all Markush groups used in the appended claims.
This application claims priority to and benefit of U.S. Provisional Patent Application No. 62/808,945, titled “PHOTOACOUSTIC COMPUTED TOMOGRAPHY” and filed on Feb. 22, 2019, which is hereby incorporated by reference in its entirety and for all purposes.
This invention was made with government support under Grant Nos. EB016963, EB016986, and CA186567 awarded by National Institutes of Health. The government has certain rights in the invention.
Number | Date | Country | |
---|---|---|---|
62808945 | Feb 2019 | US |